25
Participants
Start Date
October 5, 2015
Primary Completion Date
June 26, 2019
Study Completion Date
June 26, 2019
Varenicline
Participants take varenicline for 10 days. Each participant will be on one dosage throughout the 10 days, but not all participants receive the same dosage. The dosages that were utilized for both Parkinson's disease participants and healthy volunteers were 0.25mg once a day, 0.25mg twice a day, and 0.5mg twice a day. A fourth dosing group of 1 mg varenicline twice a day was studied in Parkinson's disease participants, but not in healthy volunteers.
University of Michigan
OTHER